- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03795545
Ultraslow SWL Versus Slow SWL for Ureteric Stones With High Attenuation Value (ESWL)
December 7, 2019 updated by: Mohammed Said ElSheemy, Cairo University
Ultraslow Full-power SWL Versus Slow SWL in Stones With High Attenuation Value
Ultraslow full-power SWL versus slow power-ramping SWL in ureteric stones with high attenuation value
Study Overview
Detailed Description
To evaluate the efficacy of ultraslow rate of SWL versus slow rate, power ramping SWL
Study Type
Interventional
Enrollment (Actual)
101
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Outside U.S./Canada
-
Banī Suwayf, Outside U.S./Canada, Egypt
- Beni-Suef Hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- single upper ureteric stone less than or equal to 2 cm
- radio-opaque stone
- high attenuation value (≥ 1000 HU) stone
Exclusion Criteria:
- Abnormal renal anatomy
- renal insufficiency
- solitary kidney
- coagulopathies
- uncontrolled hypertension
- renal artery or aortic aneurysm
- active urinary tract infection
- pregnancy
- severe skeletal malformations (spinal deformity) precluding proper stone localization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Ultraslow shock wave lithotripsy (SWL)
SWL at ultraslow rate of 30 SW/min. Power ramping at the first 100 SW from 6 to 18 kv followed by safety pause for two minutes then power ramping from 18 to 22kv during the second 100 SW followed by safety pause for another two minutes. The rest of the session at 22kv (full power). |
Shock wave lithotripsy
Other Names:
|
ACTIVE_COMPARATOR: Slow power-ramping SWL
SWL at a slow rate of 60 SW/min.
Power ramping from 6 - 10 kv during the first 500 SW then from 11 - 14 kv during the second 500 SW then from 15 - 18 kv during the following 500 SW then from 19 - 22 kv during the remaining 1000 - 1500 SW.
|
Shock wave lithotripsy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
stone free rate
Time Frame: 3 months following last session of SWL
|
Complete clearance of stones in addition to clinically insignificant residual fragments
|
3 months following last session of SWL
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complications rate
Time Frame: 3 months following last session of SWL
|
Comparison of rate of complications in both groups
|
3 months following last session of SWL
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 11, 2019
Primary Completion (ACTUAL)
July 16, 2019
Study Completion (ACTUAL)
August 12, 2019
Study Registration Dates
First Submitted
January 4, 2019
First Submitted That Met QC Criteria
January 4, 2019
First Posted (ACTUAL)
January 7, 2019
Study Record Updates
Last Update Posted (ACTUAL)
December 10, 2019
Last Update Submitted That Met QC Criteria
December 7, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16231
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ureteric Stone
-
Tor Erik SandUnknownUreteric Stent After Stone SurgeryNorway
-
Hamad Medical CorporationRecruitingUreteric Stone | Stone UreterQatar
-
Assiut UniversityUnknown
-
Zayed Military HospitalRecruiting
-
Mansoura UniversityRecruitingRenal Stone | Ureter Stone | Ureteric ObstructionEgypt
-
Chinese University of Hong KongCompleted
-
Services Hospital, LahoreCompleted
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
Clinical Trials on SWL
-
Princess Al-Johara Al-Ibrahim Cancer Research CenterCompletedRenal StonesSaudi Arabia
-
Mansoura UniversityCompletedPediatric Kidney DiseaseEgypt
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompleted
-
Cairo UniversityCompleted
-
Mansoura UniversityCompletedUrologic Diseases | Stone, Kidney | Stone, Urinary | ESWL | Radiolucent Calculus of Urinary Tract | DissolutionEgypt
-
Cairo UniversityBeni-Suef UniversityUnknown
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
Benha UniversityRecruitingTreatment Side Effects | Renal StoneEgypt
-
Al-Azhar UniversityRecruiting